drugset / Trial / NCT04040348

Alzheimer's Disease Stem Cells Multiple Infusions

NCT04040348 ↗

Phase 1 Completed 6 enrolled Bernard (Barry) Baumel
NaSingle-groupOpen-labelTreatment

Summary

The purpose of this research study is to test the safety, possible side effects, and possible effectiveness of mesenchymal stem cell infusions when given to people with a diagnosis of mild to moderate Alzheimer's disease.

Timeline

Start
2019-10-08
Primary completion
2023-04-25
Completion
2023-04-25

Drugs

EvaluationDrugModalityDoseRoute
Subject Human Mesenchymal Stem Cells Cell therapy 100 cells Intravenous

Indications